Cargando…

Characterising inflammatory markers in two childhood autoimmune diseases (JIA and JDM) pre and post methotrexate

Detalles Bibliográficos
Autores principales:	Ursu, S, Moncrieffe, H, Varsani, H, Hamaoui, RHB, Beard, L, Kassoumeri, L, Patrick, F, Wedderburn, LR
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194444/ http://dx.doi.org/10.1186/1546-0096-9-S1-O8

Ejemplares similares

Can inflammatory markers predict response to methotrexate in JIA? Results from the CHARM study
por: Moncrieffe, H, et al.
Publicado: (2011)

Methotrexate in childhood arthritis: effects on gene expression
por: Moncrieffe, H, et al.
Publicado: (2008)

PReS-FINAL-1017: Antioxidant superoxide dismutase activity is elevated in jia but not associated with disease activity
por: Radziszewska, A, et al.
Publicado: (2013)

PReS-FINAL-1001: Lymphocytes from the inflamed joint of juvenile idiopathic arthritis patients express reduced levels of cd73 and have a functional defect in adenosine production
por: Botta Gordon-Smith, S, et al.
Publicado: (2013)

Investigating which variables from the core outcome variables in juvenile idiopathic arthritis (JIA) are the best predictors of classification as a responder to treatment with methotrexate (MTX)
por: Hirani, SP, et al.
Publicado: (2008)

14.4 Oligoarticular Juvenile Idiopathic Arthritis (JIA): can extension be predicted?
por: Hunter, PJ, et al.
Publicado: (2008)

Sleep, fatigue and quality of life in juvenile idiopathic arthritis (JIA) and Juvenile Dermatomyositis (JDM)
por: Avie, Y Butbul, et al.
Publicado: (2008)

Are parents' views about their child's treatment for juvenile idiopathic arthritis (JIA) related to evaluations of their child's quality of life (QoL)? – SPARKS CHARM study
por: Mulligan, K, et al.
Publicado: (2008)

Investigating the use of a limited core outcome variable set for the classification of response following methotrexate treatment in juvenile idiopathic arthritis (JIA)
por: Hirani, SP, et al.
Publicado: (2008)

Proposal for the development of an international minimal data collection for juvenile dermatomyositis (JDM)
por: McCann, Liza J, et al.
Publicado: (2011)

Mothers’ reports of the difficulties that their children experience in taking methotrexate for Juvenile Idiopathic Arthritis and how these impact on quality of life
por: Mulligan, Kathleen, et al.
Publicado: (2013)

PReS-FINAL-1009: Antioxidant superoxide dismutase activity is paradoxically normal in juvenile systemic lupus erythematosus
por: Radziszewska, A, et al.
Publicado: (2013)

Association of the 5-aminoimidazole-4-carboxamide ribonucleotide transformylase gene with response to methotrexate in juvenile idiopathic arthritis
por: Hinks, Anne, et al.
Publicado: (2011)

Association of the IL-10 Gene Family Locus on Chromosome 1 with Juvenile Idiopathic Arthritis (JIA)
por: Omoyinmi, Ebun, et al.
Publicado: (2012)

8.5 Predictors of long-term outcome of Juvenile Dermatomyositis (JDM): a Multicenter, Multinational Study of 490 patients
por: Ferrari, C, et al.
Publicado: (2008)

PReS-FINAL-1020: Dysregulation of the peripheral blood D cell compartment is associated with disease activity in juvenile dermatomyositis
por: Piper, C, et al.
Publicado: (2013)

JDM update September 2014
por: Pilkington, Clarissa
Publicado: (2014)

Regulatory T cells from the inflamed joints of patients with juvenile idiopathic arthritis (JIA) are dysregulated and display a pro-inflammatory profile
por: Pesenacker, AM, et al.
Publicado: (2011)

Th1 and Th17 cell subpopulations are enriched in the peripheral blood of patients with systemic juvenile idiopathic arthritis
por: Omoyinmi, Ebun, et al.
Publicado: (2012)

OA05 Clinical presentation, risk factors and prognosis of MDA5-positive JDM; clinical diversity and red flags
por: McLellan, Kirsty, et al.
Publicado: (2022)

PReS-FINAL-1018: Can the CD4/CD8β ratio be used as a predictive biomarker in extended-to-be oligoarticular JIA?
por: De Leeuw, S, et al.
Publicado: (2013)

PReS-FINAL-1004: Can the cd4/cd8β ratio be used as a predictive biomarker in extended-to-be oligoarticular JIA?
por: de Leeuw, S, et al.
Publicado: (2013)

JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology
por: Ll Wilkinson, Meredyth G., et al.
Publicado: (2021)

Adverse events of methotrexate treatment in JIA
por: in ‘t Veld, J, et al.
Publicado: (2011)

An in-depth analysis of young people's experience of their juvenile idiopathic arthritis (JIA) once receiving Etanercept
por: Livermore, P, et al.
Publicado: (2008)

PReS13-SPK-1478: New developments in our care & understanding of JIA
por: Wedderburn, L
Publicado: (2013)

Juvenile dermatomyositis (JDM) sine myositis
por: Schuetz, C, et al.
Publicado: (2011)

YIM-P44. Reduced expression of cd73 on jia synovial lymphocytes is related to cell proliferation
por: Gordon-Smith, Sophie Botta, et al.
Publicado: (2014)

Development of an internationally agreed minimal dataset for juvenile dermatomyositis (JDM) for clinical and research use
por: McCann, Liza J., et al.
Publicado: (2015)

CD39: a regulatory role in childhood arthritis
por: Moncrieffe, H, et al.
Publicado: (2008)

4.4 Different phenotype of anaemia in systemic juvenile idiopathic arthritis (s-JIA) compared to anaemia in other subtypes of JIA
por: Hinze, CH, et al.
Publicado: (2008)

To evaluate the impact of a nurse-led JIA education program on parental satisfaction regarding knowledge of JIA and its management
por: Jones, J, et al.
Publicado: (2011)

Calcinosis as a complication of juvenile dermatomyositis (JDM)
por: Clara, Malagón, et al.
Publicado: (2011)

Histone antibodies as a biomarker of uveitis in JIA
por: Nordal, Ellen B, et al.
Publicado: (2014)

OA30 Genetic analysis of whole exome sequencing in a cohort of children with refractory JIA reveals genetic risk factors for rare juvenile diseases
por: Tordoff, Melissa, et al.
Publicado: (2022)

PReS-FINAL-1002: Dissecting the dissociation of foxp3 and cd25 expression on cd4+ t cells in synovial fluid identifies three distinct subpopulations of human t regulatory cells present at the chronically inflamed site
por: Bending, D, et al.
Publicado: (2013)

PReS-FINAL-2002: Adverse events during anti-TNF therapy in patients with JIA
por: Tarkiainen, M, et al.
Publicado: (2013)

The effects of early aggressive therapy in JIA: results of the TREAT study
por: Wallace, Carol A, et al.
Publicado: (2012)

PReS-FINAL-2050: Determination of the concentration of methotrexate in the blood serum of patients with JIA
por: Rokhlina, F, et al.
Publicado: (2013)

Genome-Wide Data reveals Novel Genes for Methotrexate Response in a Large Cohort of Juvenile Idiopathic Arthritis Cases
por: Cobb, Joanna, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_r0b8nks6n97rjeisbcu61ikags